Beacon Capital Management LLC (Tennessee)’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-245
Closed -$29.6K 724
2025
Q2
$29.6K Sell
245
-90
-27% -$10.1K ﹤0.01% 424
2025
Q1
$37.3K Hold
335
0.01% 366
2024
Q4
$32.6K Hold
335
﹤0.01% 375
2024
Q3
$38.5K Buy
335
+31
+10% +$3.52K 0.01% 365
2024
Q2
$32.4K Sell
304
-50
-14% -$5.02K 0.01% 363
2024
Q1
$34.2K Buy
354
+212
+149% +$21.7K 0.01% 360
2023
Q4
$14.5K Hold
142
﹤0.01% 438
2023
Q3
$14.3K Hold
142
﹤0.01% 470
2023
Q2
$14.3K Hold
142
﹤0.01% 470
2023
Q1
$13.1K Hold
142
﹤0.01% 440
2022
Q4
$12.9K Hold
142
﹤0.01% 451
2022
Q3
$12K Sell
142
-60
-30% -$4.97K ﹤0.01% 447
2022
Q2
$17K Hold
202
﹤0.01% 432
2022
Q1
$17K Buy
+202
New +$17.5K ﹤0.01% 432

Other funds holding NVS

Beacon Capital Management LLC (Tennessee)'s NVS Position: Q3 2025 in Review

Beacon Capital Management LLC (Tennessee) sold out of Novartis (NVS) in Q3 2025, closing a stake of 245 shares — an estimated $29.6K sold.

Beacon Capital Management LLC (Tennessee) first reported a position in NVS in Q1 2022 and held it in 14 quarters. The position peaked at $38.5K in Q3 2024. 1,401 funds tracked by Wall St. Rank hold NVS as of Q3 2025.

  • Beacon Capital Management LLC (Tennessee) reported no remaining Novartis position as of Q3 2025 after selling out during the quarter.
  • Beacon Capital Management LLC (Tennessee) sold 245 Novartis shares in Q3 2025, an estimated $29.6K.
  • Beacon Capital Management LLC (Tennessee) first reported a position in Novartis in Q1 2022 and held it in 14 quarters.
  • Beacon Capital Management LLC (Tennessee)'s Novartis position peaked at $38.5K in Q3 2024.
  • 1,401 funds tracked by Wall St. Rank held Novartis as of Q3 2025.

Based on Beacon Capital Management LLC (Tennessee)'s 13F filing for Q3 2025, filed 7 Nov 2025.